Publicaciones (420) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia, Vol. 44, Núm. 1, pp. 77-89

  2. Detection of binucleated nephrin-marked podocytes by flow cytometry in the urine of patients with obesity

    Journal of Nephrology

  3. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 39-50

  4. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

    EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131

  5. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 51-60

  6. Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants

    FEBS Letters, Vol. 598, Núm. 4, pp. 485-499

  7. International consensus on post-transplantation diabetes mellitus

    Nephrology Dialysis Transplantation

  8. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

  9. The error of estimated GFR in predialysis care

    Scientific Reports, Vol. 14, Núm. 1

  10. Therapeutic Exercise on Metabolic and Renal Outcomes in Patients with Chronic Kidney Disease: A Narrative Review

    Nephron, Vol. 148, Núm. 2, pp. 85-94

2023

  1. Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocol

    Basic and Clinical Pharmacology and Toxicology, Vol. 133, Núm. 3, pp. 237-253

  2. Association between Cardiovascular Health, C-Reactive Protein, and Comorbidities in Spanish Urban-Dwelling Overweight/Obese Hypertensive Patients

    Journal of Cardiovascular Development and Disease, Vol. 10, Núm. 7

  3. Beta human papillomavirus as a facilitator in the initial phase but not a perpetuator of skin carcinogenesis

    JEADV Clinical Practice

  4. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia

  5. Counterintuitive structural and functional effects due to naturally occurring mutations targeting the active site of the disease-associated NQO1 enzyme*

    FEBS Journal, Vol. 290, Núm. 7, pp. 1855-1873

  6. Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression

    American journal of physiology. Gastrointestinal and liver physiology, Vol. 325, Núm. 4, pp. G306-G317

  7. Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium

    Kidney International Reports, Vol. 8, Núm. 10, pp. 2029-2042

  8. Exercise and Prediabetes After Renal Transplantation (EXPRED-I): A Prospective Study

    Sports Medicine - Open, Vol. 9, Núm. 1

  9. Inflammation on the Waiting List Is a Risk Factor for New-Onset Prediabetes and Post-Transplant Diabetes Mellitus: A Prospective Study

    Nephron, Vol. 147, Núm. 9, pp. 560-571

  10. PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2

    Kidney International, Vol. 103, Núm. 1, pp. 207-217